Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations

37Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

Fibroblast growth factor 23 (FGF-23) is known to be produced by the bone and linked to metabolic risk. We aimed to explore circulating FGF-23 in association with fatness and insulin sensitivity, atherosclerosis and bone mineral density (BMD). Circulating intact FGF-23 (iFGF-23) and C-terminal (CtFGF-23) concentrations (ELISA) were measured in 133 middle aged men from the general population in association with insulin sensitivity (Cohort 1); and in association with fat mass and bone mineral density (DEXA) and atherosclerosis (intima media thickness, IMT) in 78 subjects (52 women) with a wide range of adiposity (Cohort 2). Circulating iFGF-23 was also measured before and after weight loss. In all subjects as a whole, serum intact and C-terminal concentrations were linearly and positively associated with BMI. In cohort 1, both serum iFGF-23 and CtFGF-23 concentrations increased with insulin resistance. Serum creatinine contributed to iFGF-23 variance, while serum ferritin and insulin sensitivity (but not BMI, age or serum creatinine) contributed to 17% of CtFGF-23 variance. In cohort 2, CtFGF-23 levels were higher in women vs. men, and increased with BMI, fat mass, fasting and post-load serum glucose, insulin, HOMA-IR and PTH, being negatively associated with circulating vitamin D and ferritin levels. The associations of CtFGF-23 with bone density in the radius, lumbar spine and carotid IMT were no longer significant after controlling for BMI. Weight loss led to decreased iFGF-23 concentrations. In summary, the associations of circulating FGF-23 concentration with parameters of glucose metabolism, bone density and atherosclerosis are dependent on iron and obesity status-associated insulin resistance. © 2013 Fernández-Real et al.

References Powered by Scopus

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1520Citations
N/AReaders
Get full text

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1303Citations
N/AReaders
Get full text

Mannheim carotid intima-media thickness consensus (2004-2006): An update on behalf of the advisory board of the 3rd and 4th Watching the Risk Symposium 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006

1212Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults

134Citations
N/AReaders
Get full text

Regulation of fibroblast growth factor 23 (FGF23) in health and disease

60Citations
N/AReaders
Get full text

Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients

55Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fernández-Real, J. M., Puig, J., Serrano, M., Sabater, M., Rubió, A., Moreno-Navarrete, J. M., … Ricart, W. (2013). Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations. PLoS ONE, 8(3). https://doi.org/10.1371/journal.pone.0058961

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

39%

Researcher 14

39%

Professor / Associate Prof. 7

19%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

53%

Agricultural and Biological Sciences 7

22%

Biochemistry, Genetics and Molecular Bi... 6

19%

Nursing and Health Professions 2

6%

Save time finding and organizing research with Mendeley

Sign up for free